J Dhaliwal1,2, M W Carroll3, J C deBruyn4, A Ricciuto1, E I Benchimol1, S Lawrence5, M Sherlock6, W El-Matary7, H Brill6,8, P Church1, E Wine3, N Carman9, A Muise1, H Huynh3, D R Mack9, T D Walters1, A M Griffiths1, K Jacobson5. 1. SickKids Hospital, University of Toronto, Toronto, ON, Canada. 2. Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. 3. Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada. 4. Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada. 5. British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada. 6. McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada. 7. Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. 8. William Osler Health System, University of Toronto, Toronto, ON, Canada. 9. Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
Abstract
BACKGROUND: Canadian-born children of South Asian [SA] ethnicity develop inflammatory bowel disease [IBD] at similar rates to those among Caucasian children. We evaluated the variation in phenotypic spectrum of IBD in SA and Caucasian children in a national paediatric inception cohort of new-onset IBD. METHODS: Patients aged <17 years, enrolled in a Canadian nationwide inception cohort study, were included. Baseline demographic and IBD phenotypic features were compared between SA and Caucasian children. Longitudinal outcomes through 18 months of follow-up were compared matched by propensity scores. RESULTS: Of 1156 children enrolled over 2014 to 2019, 623 were Caucasian [98% and 88% parents Canadian born] and 114 SA [79% Canadian born, 87% parents SA born]. Fewer SAs have a first-degree relative with IBD, 6% vs 19% in Caucasians, p = 0.002. SAs present at a younger age, median age 11.4 years (interquartile range [IQR] 9.2-14.3) vs 13 years [IQR 10.9-15 years], p = 0.03 and more commonly with a UC/IBD-U [ulcerative colitis/IBD-unclassified] subtype [ratio of UC/IBD-U to CD 1.2:1 vs 1:1.8 for Caucasians, p <0.001]. Additionally, a greater proportion of SA CD patients present with colonic-only disease [colonic-only CD/UC/IBD-U in SAs 67% vs 57% for Caucasians, p = 0.001], and among those with CD, colonic CD in SAs 31% vs 23% in Caucasians, p = 0.20]. Perianal fistulising disease was also numerically more common in SAs (14 [27%] vs 64 [18%], p = 0.06]. Adjusting for differences in phenotypic presentation, anti-tumour necrosis factor [TNF] exposure, and time to initiation was similar, and two-thirds of children, whether anti-TNF exposed or naïve, were in corticosteroid-free clinical remission at 18 months irrespective of ethnicity. CONCLUSIONS: The phenotypic spectrum of new-onset IBD in SA children differs from that of Caucasian children, but treatment and clinical course are similar within phenotypic subgroups.
BACKGROUND: Canadian-born children of South Asian [SA] ethnicity develop inflammatory bowel disease [IBD] at similar rates to those among Caucasian children. We evaluated the variation in phenotypic spectrum of IBD in SA and Caucasian children in a national paediatric inception cohort of new-onset IBD. METHODS: Patients aged <17 years, enrolled in a Canadian nationwide inception cohort study, were included. Baseline demographic and IBD phenotypic features were compared between SA and Caucasian children. Longitudinal outcomes through 18 months of follow-up were compared matched by propensity scores. RESULTS: Of 1156 children enrolled over 2014 to 2019, 623 were Caucasian [98% and 88% parents Canadian born] and 114 SA [79% Canadian born, 87% parents SA born]. Fewer SAs have a first-degree relative with IBD, 6% vs 19% in Caucasians, p = 0.002. SAs present at a younger age, median age 11.4 years (interquartile range [IQR] 9.2-14.3) vs 13 years [IQR 10.9-15 years], p = 0.03 and more commonly with a UC/IBD-U [ulcerative colitis/IBD-unclassified] subtype [ratio of UC/IBD-U to CD 1.2:1 vs 1:1.8 for Caucasians, p <0.001]. Additionally, a greater proportion of SA CD patients present with colonic-only disease [colonic-only CD/UC/IBD-U in SAs 67% vs 57% for Caucasians, p = 0.001], and among those with CD, colonic CD in SAs 31% vs 23% in Caucasians, p = 0.20]. Perianal fistulising disease was also numerically more common in SAs (14 [27%] vs 64 [18%], p = 0.06]. Adjusting for differences in phenotypic presentation, anti-tumour necrosis factor [TNF] exposure, and time to initiation was similar, and two-thirds of children, whether anti-TNF exposed or naïve, were in corticosteroid-free clinical remission at 18 months irrespective of ethnicity. CONCLUSIONS: The phenotypic spectrum of new-onset IBD in SA children differs from that of Caucasian children, but treatment and clinical course are similar within phenotypic subgroups.
Authors: J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths Journal: J Crohns Colitis Date: 2020-05-21 Impact factor: 9.071
Authors: David G Walker; Horace R T Williams; Stephen P Kane; Joel E Mawdsley; Jayantha Arnold; Ian McNeil; Huw J W Thomas; Julian P Teare; Ailsa L Hart; Maxton C L Pitcher; Julian R F Walters; Sara E Marshall; Timothy R Orchard Journal: Am J Gastroenterol Date: 2011-05-17 Impact factor: 10.864
Authors: Eric I Benchimol; David R Mack; Astrid Guttmann; Geoffrey C Nguyen; Teresa To; Nassim Mojaverian; Pauline Quach; Douglas G Manuel Journal: Am J Gastroenterol Date: 2015-03-10 Impact factor: 10.864
Authors: Siew C Ng; Gilaad G Kaplan; Whitney Tang; Rupa Banerjee; Bhargavi Adigopula; Fox E Underwood; Divine Tanyingoh; Shu-Chen Wei; Wei-Chen Lin; Hung-Hsin Lin; Jin Li; Sally Bell; Olga Niewiadomski; Michael A Kamm; Zhirong Zeng; Minhu Chen; Pinjin Hu; David Ong; Choon Jin Ooi; Khoon-Lin Ling; Yinglei Miao; Jiarong Miao; H Janaka de Silva; Madunil Niriella; Satimai Aniwan; Julajak Limsrivilai; Pises Pisespongsa; Kaichun Wu; Hong Yang; Ka Kei Ng; Hon Ho Yu; Yufang Wang; Qin Ouyang; Murdani Abdullah; Marcellus Simadibrata; Jeffri Gunawan; Ida Hilmi; Khean Lee Goh; Qian Cao; Hong Sheng; Arlinking Ong-Go; Vui Heng Chong; Jessica Y L Ching; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung Journal: Am J Gastroenterol Date: 2019-01 Impact factor: 10.864
Authors: Eric I Benchimol; Douglas G Manuel; Teresa To; David R Mack; Geoffrey C Nguyen; Jennifer L Gommerman; Kenneth Croitoru; Nassim Mojaverian; Xuesong Wang; Pauline Quach; Astrid Guttmann Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240
Authors: Ravi Misra; Jimmy Limdi; Rachel Cooney; Samia Sakuma; Matthew Brookes; Edward Fogden; Sanjeev Pattni; Naveen Sharma; Tariq Iqbal; Pia Munkholm; Johan Burisch; Naila Arebi Journal: World J Gastroenterol Date: 2019-10-28 Impact factor: 5.742
Authors: Isabelle Cleynen; Gabrielle Boucher; Luke Jostins; L Philip Schumm; Sebastian Zeissig; Tariq Ahmad; Vibeke Andersen; Jane M Andrews; Vito Annese; Stephan Brand; Steven R Brant; Judy H Cho; Mark J Daly; Marla Dubinsky; Richard H Duerr; Lynnette R Ferguson; Andre Franke; Richard B Gearry; Philippe Goyette; Hakon Hakonarson; Jonas Halfvarson; Johannes R Hov; Hailang Huang; Nicholas A Kennedy; Limas Kupcinskas; Ian C Lawrance; James C Lee; Jack Satsangi; Stephan Schreiber; Emilie Théâtre; Andrea E van der Meulen-de Jong; Rinse K Weersma; David C Wilson; Miles Parkes; Severine Vermeire; John D Rioux; John Mansfield; Mark S Silverberg; Graham Radford-Smith; Dermot P B McGovern; Jeffrey C Barrett; Charlie W Lees Journal: Lancet Date: 2015-10-18 Impact factor: 202.731